Oxygenta Pharmaceutical Ltd — Important, 19-08-2025: Company Update

Oxygenta Pharmaceutical Limited announced significant leadership changes with the resignation of Mr. Vankineni Sai Sudhakar from his roles as Managing Director and Chief Financial Officer. Separately, Mr. Sanagari Kondal Reddy has also resigned as an Independent Director. Both departures stem from a recent change in the company's ownership and management, indicating a strategic transition at the top. This overhaul in key leadership positions is a direct consequence of the takeover, signaling potential shifts in the company's operational strategies and future direction. Investors should monitor how these changes impact the company's path forward.